Global and Europe Natural Source Antitumor Medicine Market - Analysis and Outlook to 2022

August 2017 | 123 pages | ID: G8768C60329EN
EU Research

Abstracts

This report presents a comprehensive overview of the Natural Source Antitumor Medicine market in Europe, which shares the history data information from 2012 to 2016, and forecast from 2017 to 2022.

This report provides a detailed analysis of the market, including its dynamics, structure, characteristics, main players, growth and demand drivers, etc. As a Detailed Analysis report, it covers all details inside analysis and opinion in Natural Source Antitumor Medicine industry.

This report focuses Global and Europe market, including details as following:

Key Players

• CIPLA LIMITED IN 400 013 Mumbai
• DR. REDDY'S LABORATORIES LIMITED IN 500 034 Hyderabad
• FRESENIUS KABI ONCOLOGY LIMITED IN 741 235 Kalyani
• Gedeon Richter Plc. HU 1103 Budapest
• HOSPIRA BOULDER, INC. US 80301 Boulder
• Indena S.p.A. IT 20139 Milano
• JIANGSU HENGRUI MEDICINE CO., LTD. CN 222 047 Lianyungang
• MINAKEM HIGH POTENT BE 1435 Mont-Saint-Guibert
• NIPPON KAYAKU CO., LTD. JP 100-0005 Tokyo
• PHYTON BIOTECH LLC CA V3M 6P7 Delta
• POLYMED THERAPEUTICS, INC. US 77056 Houston
• Sanmar Speciality Chemicals Limited IN 600 086 Chennai
• SANOFI CHIMIE FR 94250 Gentilly
• SCINOPHARM TAIWAN, LTD. TW 74144 Shan-Hua
• TEVA CZECH INDUSTRIES S.R.O. CZ 747 70 Opava-Komarov

Key Regions

• North America
• United States
• Canada
• Latin America
• Mexico
• Brazil
• Argentina
• Others
• Europe
• Germany
• United Kingdom
• France
• Italy
• Spain
• Russia
• Netherland
• Others
• Asia & Pacific
• China
• Japan
• India
• Korea
• Australia
• Southeast Asia
• Indonesia
• Thailand
• Philippines
• Vietnam
• Singapore
• Malaysia
• Others
• Africa & Middle East
• South Africa
• Egypt
• Turkey
• Saudi Arabia
• Iran
• Others

Key Product Type

Natural Source Antitumor Medicine Market, by Natural Source

• Topotecan
• Camptothecin
• Rubitecan
• Paclitaxel
• Colchicine
• Etoposide
• Docetaxel
• Resveratrol
• Podophyllotoxin
• Irinotecan
• Cantharidin
• Harringtonolide
• Vinblastine
• Epothilone

Key Applications

• Department of Oncology
• Department of Chemotherapy
• Pharmacology

Contents

1 MARKET OUTLINE

1.1 Research Methodology
  1.1.1 Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
  1.1.2 Data Source
Secondary Sources
Primary Sources
  1.1.3 Disclaimer
1.2 Regulatory Factors
1.3 End-User Analysis
1.4 Strategic Benchmarking
1.5 Industry Chain and Supply Chain
  1.5.1 Natural Source Antitumor Medicine Industry Chain Structure
    1.5.1.1 R&D
    1.5.1.2 Raw Materials (Components)
    1.5.1.3 Manufacturing Plants
    1.5.1.4 Regional Trading (Import Export and Local Sales)
    1.5.1.5 Online Sales Channel
    1.5.1.6 Offline Channel
    1.5.1.7 End Users
  1.5.2 Natural Source Antitumor Medicine Manufacturing
    1.5.2.1 Key Components
    1.5.2.2 Assembly Manufacturing
  1.5.3 Consumer Preference
  1.5.4 Behavioral Habits
  1.5.5 Marketing Environment
1.6 SWOT Analysis
1.7 Feasibility Analysis
1.8 Development Trend and Research Conclusion
  1.8.1 Development Trend
  1.8.2 Research Conclusion

2 GLOBAL NATURAL SOURCE ANTITUMOR MEDICINE PRODUCT OVERVIEW

2.1 Global Natural Source Antitumor Medicine Market Sales Volume Revenue and Price 2012-2017
2.2 Natural Source Antitumor Medicine, by Natural Source 2012-2017
  2.2.1 Global Natural Source Antitumor Medicine Sales Market Share by Natural Source 2012-2017
  2.2.2 Global Natural Source Antitumor Medicine Revenue Market Share by Natural Source 2012-2017
  2.2.3 Global Natural Source Antitumor Medicine Price by Natural Source 2012-2017
  2.2.4 Topotecan
  2.2.5 Camptothecin
  2.2.6 Rubitecan
  2.2.7 Paclitaxel
  2.2.8 Colchicine
Etoposide
Docetaxel
Resveratrol
Podophyllotoxin
Irinotecan
Cantharidin
Harringtonolide
Vinblastine
Epothilone

3 EUROPE NATURAL SOURCE ANTITUMOR MEDICINE PRODUCT OVERVIEW

3.1 Europe Natural Source Antitumor Medicine Market Sales Volume Revenue and Price 2012-2017
3.2 Natural Source Antitumor Medicine, by Natural Source 2012-2017
  3.2.1 Europe Natural Source Antitumor Medicine Sales Market Share by Natural Source 2012-2017
  3.2.2 Europe Natural Source Antitumor Medicine Revenue Market Share by Natural Source 2012-2017
  3.2.3 Europe Natural Source Antitumor Medicine Price by Natural Source 2012-2017
  3.2.4 Topotecan
  3.2.5 Camptothecin
  3.2.6 Rubitecan
  3.2.7 Paclitaxel
  3.2.8 Colchicine
Etoposide
Docetaxel
Resveratrol
Podophyllotoxin
Irinotecan
Cantharidin
Harringtonolide
Vinblastine
Epothilone

4 NATURAL SOURCE ANTITUMOR MEDICINE TOP COMPANIES PROFILE

4.1 CIPLA LIMITED IN 400 013 Mumbai
  4.1.1 CIPLA LIMITED IN 400 013 Mumbai Company Details and Competitors
  4.1.2 CIPLA LIMITED IN 400 013 Mumbai Key Natural Source Antitumor Medicine Models and Performance
  4.1.3 CIPLA LIMITED IN 400 013 Mumbai Natural Source Antitumor Medicine Business SWOT Analysis and Forecast
  4.1.4 CIPLA LIMITED IN 400 013 Mumbai Natural Source Antitumor Medicine Sales Volume Revenue Price Cost and Gross Margin
4.2 DR. REDDY'S LABORATORIES LIMITED IN 500 034 Hyderabad
  4.2.1 DR. REDDY'S LABORATORIES LIMITED IN 500 034 Hyderabad Company Details and Competitors
  4.2.2 DR. REDDY'S LABORATORIES LIMITED IN 500 034 Hyderabad Key Natural Source Antitumor Medicine Models and Performance
  4.2.3 DR. REDDY'S LABORATORIES LIMITED IN 500 034 Hyderabad Natural Source Antitumor Medicine Business SWOT Analysis and Forecast
  4.2.4 DR. REDDY'S LABORATORIES LIMITED IN 500 034 Hyderabad Natural Source Antitumor Medicine Sales Volume Revenue Price Cost and Gross Margin
4.3 FRESENIUS KABI ONCOLOGY LIMITED IN 741 235 Kalyani
  4.3.1 FRESENIUS KABI ONCOLOGY LIMITED IN 741 235 Kalyani Company Details and Competitors
  4.3.2 FRESENIUS KABI ONCOLOGY LIMITED IN 741 235 Kalyani Key Natural Source Antitumor Medicine Models and Performance
  4.3.3 FRESENIUS KABI ONCOLOGY LIMITED IN 741 235 Kalyani Natural Source Antitumor Medicine Business SWOT Analysis and Forecast
  4.3.4 FRESENIUS KABI ONCOLOGY LIMITED IN 741 235 Kalyani Natural Source Antitumor Medicine Sales Volume Revenue Price Cost and Gross Margin
4.4 Gedeon Richter Plc. HU 1103 Budapest
  4.4.1 Gedeon Richter Plc. HU 1103 Budapest Company Details and Competitors
  4.4.2 Gedeon Richter Plc. HU 1103 Budapest Key Natural Source Antitumor Medicine Models and Performance
  4.4.3 Gedeon Richter Plc. HU 1103 Budapest Natural Source Antitumor Medicine Business SWOT Analysis and Forecast
  4.4.4 Gedeon Richter Plc. HU 1103 Budapest Natural Source Antitumor Medicine Sales Volume Revenue Price Cost and Gross Margin
4.5 HOSPIRA BOULDER, INC. US 80301 Boulder
  4.5.1 HOSPIRA BOULDER, INC. US 80301 Boulder Company Details and Competitors
  4.5.2 HOSPIRA BOULDER, INC. US 80301 Boulder Key Natural Source Antitumor Medicine Models and Performance
  4.5.3 HOSPIRA BOULDER, INC. US 80301 Boulder Natural Source Antitumor Medicine Business SWOT Analysis and Forecast
  4.5.4 HOSPIRA BOULDER, INC. US 80301 Boulder Natural Source Antitumor Medicine Sales Volume Revenue Price Cost and Gross Margin
4.6 Indena S.p.A. IT 20139 Milano
  4.6.1 Indena S.p.A. IT 20139 Milano Company Details and Competitors
  4.6.2 Indena S.p.A. IT 20139 Milano Key Natural Source Antitumor Medicine Models and Performance
  4.6.3 Indena S.p.A. IT 20139 Milano Natural Source Antitumor Medicine Business SWOT Analysis and Forecast
  4.6.4 Indena S.p.A. IT 20139 Milano Natural Source Antitumor Medicine Sales Volume Revenue Price Cost and Gross Margin
4.7 JIANGSU HENGRUI MEDICINE CO., LTD. CN 222 047 Lianyungang
  4.7.1 JIANGSU HENGRUI MEDICINE CO., LTD. CN 222 047 Lianyungang Company Details and Competitors
  4.7.2 JIANGSU HENGRUI MEDICINE CO., LTD. CN 222 047 Lianyungang Key Natural Source Antitumor Medicine Models and Performance
  4.7.3 JIANGSU HENGRUI MEDICINE CO., LTD. CN 222 047 Lianyungang Natural Source Antitumor Medicine Business SWOT Analysis and Forecast
  4.7.4 JIANGSU HENGRUI MEDICINE CO., LTD. CN 222 047 Lianyungang Natural Source Antitumor Medicine Sales Volume Revenue Price Cost and Gross Margin
4.8 MINAKEM HIGH POTENT BE 1435 Mont-Saint-Guibert
  4.8.1 MINAKEM HIGH POTENT BE 1435 Mont-Saint-Guibert Company Details and Competitors
  4.8.2 MINAKEM HIGH POTENT BE 1435 Mont-Saint-Guibert Key Natural Source Antitumor Medicine Models and Performance
  4.8.3 MINAKEM HIGH POTENT BE 1435 Mont-Saint-Guibert Natural Source Antitumor Medicine Business SWOT Analysis and Forecast
  4.8.4 MINAKEM HIGH POTENT BE 1435 Mont-Saint-Guibert Natural Source Antitumor Medicine Sales Volume Revenue Price Cost and Gross Margin
4.9 NIPPON KAYAKU CO., LTD. JP 100-0005 Tokyo
  4.9.1 NIPPON KAYAKU CO., LTD. JP 100-0005 Tokyo Company Details and Competitors
  4.9.2 NIPPON KAYAKU CO., LTD. JP 100-0005 Tokyo Key Natural Source Antitumor Medicine Models and Performance
  4.9.3 NIPPON KAYAKU CO., LTD. JP 100-0005 Tokyo Natural Source Antitumor Medicine Business SWOT Analysis and Forecast
  4.9.4 NIPPON KAYAKU CO., LTD. JP 100-0005 Tokyo Natural Source Antitumor Medicine Sales Volume Revenue Price Cost and Gross Margin
4.10 PHYTON BIOTECH LLC CA V3M 6P7 Delta
  4.10.1 PHYTON BIOTECH LLC CA V3M 6P7 Delta Company Details and Competitors
  4.10.2 PHYTON BIOTECH LLC CA V3M 6P7 Delta Key Natural Source Antitumor Medicine Models and Performance
  4.10.3 PHYTON BIOTECH LLC CA V3M 6P7 Delta Natural Source Antitumor Medicine Business SWOT Analysis and Forecast
  4.10.4 PHYTON BIOTECH LLC CA V3M 6P7 Delta Natural Source Antitumor Medicine Sales Volume Revenue Price Cost and Gross Margin
4.11 POLYMED THERAPEUTICS, INC. US 77056 Houston
4.12 Sanmar Speciality Chemicals Limited IN 600 086 Chennai
4.13 SANOFI CHIMIE FR 94250 Gentilly
4.14 SCINOPHARM TAIWAN, LTD. TW 74144 Shan-Hua
4.15 TEVA CZECH INDUSTRIES S.R.O. CZ 747 70 Opava-Komarov

5 NATURAL SOURCE ANTITUMOR MEDICINE BY REGIONS 2012-2017

5.1 Global Natural Source Antitumor Medicine Sales Market Share by Regions 2012-2017
5.2 Global Natural Source Antitumor Medicine Revenue Market Share by Regions 2012-2017
5.3 Global Natural Source Antitumor Medicine Price by Regions 2012-2017
5.4 North America
  5.4.1 United States
  5.4.2 Canada
5.5 Latin America
  5.5.1 Mexico
  5.5.2 Brazil
  5.5.3 Argentina
  5.5.4 Others in Latin America
5.6 Europe
  5.6.1 Germany
  5.6.2 United Kingdom
  5.6.3 France
  5.6.4 Italy
  5.6.5 Spain
  5.6.6 Russia
  5.6.7 Netherland
  5.6.8 Others in Europe
5.7 Asia & Pacific
  5.7.1 China
  5.7.2 Japan
  5.7.3 India
  5.7.4 Korea
  5.7.5 Australia
  5.7.6 Southeast Asia
    5.7.6.1 Indonesia
    5.7.6.2 Thailand
    5.7.6.3 Philippines
    5.7.6.4 Vietnam
    5.7.6.5 Singapore
    5.7.6.6 Malaysia
    5.7.6.7 Others in Southeast Asia
5.8 Africa & Middle East
  5.8.1 South Africa
  5.8.2 Egypt
  5.8.3 Turkey
  5.8.4 Saudi Arabia
  5.8.5 Iran
  5.8.6 Others in Africa & Middle East

6 GLOBALNATURAL SOURCE ANTITUMOR MEDICINE BY PLAYERS 2012-2017

6.1 Global Natural Source Antitumor Medicine Sales Volume Market Share by Brands 2012-2017
6.2 Global Natural Source Antitumor Medicine Revenue Share by Brands 2012-2017
6.3 Global Top Players Natural Source Antitumor Medicine Key Product Model and Market Performance
6.4 Global Top Players Natural Source Antitumor Medicine Key Target Consumers and Market Performance

7 EUROPENATURAL SOURCE ANTITUMOR MEDICINE BY PLAYERS 2012-2017

7.1 Europe Natural Source Antitumor Medicine Sales Volume Market Share by Brands 2012-2017
7.2 Europe Natural Source Antitumor Medicine Revenue Share by Brands 2012-2017
7.3 Europe Top Players Natural Source Antitumor Medicine Key Product Model and Market Performance
7.4 Europe Top Players Natural Source Antitumor Medicine Key Target Consumers and Market Performance

8 GLOBAL NATURAL SOURCE ANTITUMOR MEDICINE BY CONSUMER 2012-2017

8.1 Global Natural Source Antitumor Medicine Sales Market Share by Consumer 2012-2017
8.2 Department of Oncology
8.3 Department of Chemotherapy
8.4 Pharmacology
8.5 Consuming Habit and Preference

9 EUROPE NATURAL SOURCE ANTITUMOR MEDICINE BY CONSUMER 2012-2017

9.1 Europe Natural Source Antitumor Medicine Sales Market Share by Consumer 2012-2017
9.2 Department of Oncology
9.3 Department of Chemotherapy
9.4 Pharmacology
9.5 Consuming Habit and Preference

10 GLOBAL NATURAL SOURCE ANTITUMOR MEDICINE MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

10.1 Global Natural Source Antitumor Medicine Sales (), Revenue (Million USD) Forecast (2017-2022)
10.2 Global Natural Source Antitumor Medicine Sales () Forecast by Regions (2017-2022)
10.3 Global Natural Source Antitumor Medicine Sales () Forecast by Application (2017-2022)
10.4 Global Natural Source Antitumor Medicine Sales () Forecast by Natural Source (2017-2022)
10.5 Global Natural Source Antitumor Medicine Sales () Forecast by (2017-2022)

11 EUROPE NATURAL SOURCE ANTITUMOR MEDICINE MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

11.1 Europe Natural Source Antitumor Medicine Sales (), Revenue (Million USD) Forecast (2017-2022)
11.2 Europe Natural Source Antitumor Medicine Sales () Forecast by Regions (2017-2022)
11.3 Europe Natural Source Antitumor Medicine Sales () Forecast by Application (2017-2022)
11.4 Europe Natural Source Antitumor Medicine Sales () Forecast by Natural Source (2017-2022)
11.5 Europe Natural Source Antitumor Medicine Sales () Forecast by (2017-2022)

List Of Tables

LIST OF TABLES AND FIGURES

Table Global Natural Source Antitumor Medicine Sales Volume (), Revenue (Million USD) and Price ()(2012-2017)
Figure Global Natural Source Antitumor Medicine Revenue (Million USD) and Growth Rate (2012-2017)
Figure Global Natural Source Antitumor Medicine Sales Volume () and Growth Rate (2012-2017)
Table Global Natural Source Antitumor Medicine Sales () by Natural Source (2012-2017)
Table Global Natural Source Antitumor Medicine Sales Market Share by Natural Source (2012-2017)
Figure Global Natural Source Antitumor Medicine Sales Market Share by Natural Source in 2016
Table Global Natural Source Antitumor Medicine Revenue (Million USD) by Natural Source (2012-2017)
Table Global Natural Source Antitumor Medicine Revenue Market Share by Natural Source (2012-2017)
Figure Global Natural Source Antitumor Medicine Revenue Market Share by Natural Source in 2016
Table Global Natural Source Antitumor Medicine Price () by Natural Source (2012-2017)
Table Top Players of Topotecan Natural Source Antitumor Medicine Products List
Figure Global Topotecan Natural Source Antitumor Medicine Sales () and Growth Rate (2012-2017)
Table Top Players of Camptothecin Natural Source Antitumor Medicine Products List
Figure Global Camptothecin Natural Source Antitumor Medicine Sales () and Growth Rate (2012-2017)
Table Top Players of Rubitecan Natural Source Antitumor Medicine Products List
Figure Global Rubitecan Natural Source Antitumor Medicine Sales () and Growth Rate (2012-2017)
Table Top Players of Paclitaxel Natural Source Antitumor Medicine Products List
Figure Global Paclitaxel Natural Source Antitumor Medicine Sales () and Growth Rate (2012-2017)
Table Top Players of Colchicine Natural Source Antitumor Medicine Products List
Figure Global Colchicine Natural Source Antitumor Medicine Sales () and Growth Rate (2012-2017)
Table Global Natural Source Antitumor Medicine Sales () by (2012-2017)
Table Global Natural Source Antitumor Medicine Sales Market Share by (2012-2017)
Figure Global Natural Source Antitumor Medicine Sales Market Share by in 2016
Table Global Natural Source Antitumor Medicine Revenue (Million USD) by (2012-2017)
Table Global Natural Source Antitumor Medicine Revenue Market Share by (2012-2017)
Figure Global Natural Source Antitumor Medicine Revenue Market Share by in 2016
Table Global Natural Source Antitumor Medicine Price () by (2012-2017)
Table Global Natural Source Antitumor Medicine Sales () by (2012-2017)
Table Global Natural Source Antitumor Medicine Sales Market Share by (2012-2017)
Figure Global Natural Source Antitumor Medicine Sales Market Share by in 2016
Table Global Natural Source Antitumor Medicine Revenue (Million USD) by (2012-2017)
Table Global Natural Source Antitumor Medicine Revenue Market Share by (2012-2017)
Figure Global Natural Source Antitumor Medicine Revenue Market Share by in 2016
Table Global Natural Source Antitumor Medicine Price () by (2012-2017)
Table Europe Natural Source Antitumor Medicine Sales Volume (), Revenue (Million USD) and Price ()(2012-2017)
Figure Europe Natural Source Antitumor Medicine Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Natural Source Antitumor Medicine Sales Volume () and Growth Rate (2012-2017)
Table Europe Natural Source Antitumor Medicine Sales () by Natural Source (2012-2017)
Table Europe Natural Source Antitumor Medicine Sales Market Share by Natural Source (2012-2017)
Figure Europe Natural Source Antitumor Medicine Sales Market Share by Natural Source in 2016
Table Europe Natural Source Antitumor Medicine Revenue (Million USD) by Natural Source (2012-2017)
Table Europe Natural Source Antitumor Medicine Revenue Market Share by Natural Source (2012-2017)
Figure Europe Natural Source Antitumor Medicine Revenue Market Share by Natural Source in 2016
Table Europe Natural Source Antitumor Medicine Price () by Natural Source (2012-2017)
Table Top Players of Topotecan Natural Source Antitumor Medicine Products List
Figure Europe Topotecan Natural Source Antitumor Medicine Sales () and Growth Rate (2012-2017)
Table Top Players of Camptothecin Natural Source Antitumor Medicine Products List
Figure Europe Camptothecin Natural Source Antitumor Medicine Sales () and Growth Rate (2012-2017)
Table Top Players of Rubitecan Natural Source Antitumor Medicine Products List
Figure Europe Rubitecan Natural Source Antitumor Medicine Sales () and Growth Rate (2012-2017)
Table Top Players of Paclitaxel Natural Source Antitumor Medicine Products List
Figure Europe Paclitaxel Natural Source Antitumor Medicine Sales () and Growth Rate (2012-2017)
Table Top Players of Colchicine Natural Source Antitumor Medicine Products List
Figure Europe Colchicine Natural Source Antitumor Medicine Sales () and Growth Rate (2012-2017)
Table Europe Natural Source Antitumor Medicine Sales () by (2012-2017)
Table Europe Natural Source Antitumor Medicine Sales Market Share by (2012-2017)
Figure Europe Natural Source Antitumor Medicine Sales Market Share by in 2016
Table Europe Natural Source Antitumor Medicine Revenue (Million USD) by (2012-2017)
Table Europe Natural Source Antitumor Medicine Revenue Market Share by (2012-2017)
Figure Europe Natural Source Antitumor Medicine Revenue Market Share by in 2016
Table Europe Natural Source Antitumor Medicine Price () by (2012-2017)
Table Europe Natural Source Antitumor Medicine Sales () by (2012-2017)
Table Europe Natural Source Antitumor Medicine Sales Market Share by (2012-2017)
Figure Europe Natural Source Antitumor Medicine Sales Market Share by in 2016
Table Europe Natural Source Antitumor Medicine Revenue (Million USD) by (2012-2017)
Table Europe Natural Source Antitumor Medicine Revenue Market Share by (2012-2017)
Figure Europe Natural Source Antitumor Medicine Revenue Market Share by in 2016
Table Europe Natural Source Antitumor Medicine Price () by (2012-2017)
Table CIPLA LIMITED IN 400 013 Mumbai Company Details and Competitors
Table CIPLA LIMITED IN 400 013 Mumbai Key Natural Source Antitumor Medicine Models and Performance
Table CIPLA LIMITED IN 400 013 Mumbai Natural Source Antitumor Medicine Business SWOT Analysis and Forecast
Table CIPLA LIMITED IN 400 013 Mumbai Natural Source Antitumor Medicine Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure CIPLA LIMITED IN 400 013 Mumbai Natural Source Antitumor Medicine Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure CIPLA LIMITED IN 400 013 Mumbai Natural Source Antitumor Medicine Sales Market Share (%) in Global (2012-2017)
Figure CIPLA LIMITED IN 400 013 Mumbai Natural Source Antitumor Medicine Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure CIPLA LIMITED IN 400 013 Mumbai Natural Source Antitumor Medicine Revenue Market Share (%) in Global (2012-2017)
Table DR. REDDY'S LABORATORIES LIMITED IN 500 034 Hyderabad Company Details and Competitors
Table DR. REDDY'S LABORATORIES LIMITED IN 500 034 Hyderabad Key Natural Source Antitumor Medicine Models and Performance
Table DR. REDDY'S LABORATORIES LIMITED IN 500 034 Hyderabad Natural Source Antitumor Medicine Business SWOT Analysis and Forecast
Table DR. REDDY'S LABORATORIES LIMITED IN 500 034 Hyderabad Natural Source Antitumor Medicine Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure DR. REDDY'S LABORATORIES LIMITED IN 500 034 Hyderabad Natural Source Antitumor Medicine Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure DR. REDDY'S LABORATORIES LIMITED IN 500 034 Hyderabad Natural Source Antitumor Medicine Sales Market Share (%) in Global (2012-2017)
Figure DR. REDDY'S LABORATORIES LIMITED IN 500 034 Hyderabad Natural Source Antitumor Medicine Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure DR. REDDY'S LABORATORIES LIMITED IN 500 034 Hyderabad Natural Source Antitumor Medicine Revenue Market Share (%) in Global (2012-2017)
Table FRESENIUS KABI ONCOLOGY LIMITED IN 741 235 Kalyani Company Details and Competitors
Table FRESENIUS KABI ONCOLOGY LIMITED IN 741 235 Kalyani Key Natural Source Antitumor Medicine Models and Performance
Table FRESENIUS KABI ONCOLOGY LIMITED IN 741 235 Kalyani Natural Source Antitumor Medicine Business SWOT Analysis and Forecast
Table FRESENIUS KABI ONCOLOGY LIMITED IN 741 235 Kalyani Natural Source Antitumor Medicine Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure FRESENIUS KABI ONCOLOGY LIMITED IN 741 235 Kalyani Natural Source Antitumor Medicine Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure FRESENIUS KABI ONCOLOGY LIMITED IN 741 235 Kalyani Natural Source Antitumor Medicine Sales Market Share (%) in Global (2012-2017)
Figure FRESENIUS KABI ONCOLOGY LIMITED IN 741 235 Kalyani Natural Source Antitumor Medicine Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure FRESENIUS KABI ONCOLOGY LIMITED IN 741 235 Kalyani Natural Source Antitumor Medicine Revenue Market Share (%) in Global (2012-2017)
Table Gedeon Richter Plc. HU 1103 Budapest Company Details and Competitors
Table Gedeon Richter Plc. HU 1103 Budapest Key Natural Source Antitumor Medicine Models and Performance
Table Gedeon Richter Plc. HU 1103 Budapest Natural Source Antitumor Medicine Business SWOT Analysis and Forecast
Table Gedeon Richter Plc. HU 1103 Budapest Natural Source Antitumor Medicine Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure Gedeon Richter Plc. HU 1103 Budapest Natural Source Antitumor Medicine Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure Gedeon Richter Plc. HU 1103 Budapest Natural Source Antitumor Medicine Sales Market Share (%) in Global (2012-2017)
Figure Gedeon Richter Plc. HU 1103 Budapest Natural Source Antitumor Medicine Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Gedeon Richter Plc. HU 1103 Budapest Natural Source Antitumor Medicine Revenue Market Share (%) in Global (2012-2017)
Table HOSPIRA BOULDER, INC. US 80301 Boulder Company Details and Competitors
Table HOSPIRA BOULDER, INC. US 80301 Boulder Key Natural Source Antitumor Medicine Models and Performance
Table HOSPIRA BOULDER, INC. US 80301 Boulder Natural Source Antitumor Medicine Business SWOT Analysis and Forecast
Table HOSPIRA BOULDER, INC. US 80301 Boulder Natural Source Antitumor Medicine Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure HOSPIRA BOULDER, INC. US 80301 Boulder Natural Source Antitumor Medicine Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure HOSPIRA BOULDER, INC. US 80301 Boulder Natural Source Antitumor Medicine Sales Market Share (%) in Global (2012-2017)
Figure HOSPIRA BOULDER, INC. US 80301 Boulder Natural Source Antitumor Medicine Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure HOSPIRA BOULDER, INC. US 80301 Boulder Natural Source Antitumor Medicine Revenue Market Share (%) in Global (2012-2017)
Table Indena S.p.A. IT 20139 Milano Company Details and Competitors
Table Indena S.p.A. IT 20139 Milano Key Natural Source Antitumor Medicine Models and Performance
Table Indena S.p.A. IT 20139 Milano Natural Source Antitumor Medicine Business SWOT Analysis and Forecast
Table Indena S.p.A. IT 20139 Milano Natural Source Antitumor Medicine Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure Indena S.p.A. IT 20139 Milano Natural Source Antitumor Medicine Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure Indena S.p.A. IT 20139 Milano Natural Source Antitumor Medicine Sales Market Share (%) in Global (2012-2017)
Figure Indena S.p.A. IT 20139 Milano Natural Source Antitumor Medicine Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Indena S.p.A. IT 20139 Milano Natural Source Antitumor Medicine Revenue Market Share (%) in Global (2012-2017)
Table JIANGSU HENGRUI MEDICINE CO., LTD. CN 222 047 Lianyungang Company Details and Competitors
Table JIANGSU HENGRUI MEDICINE CO., LTD. CN 222 047 Lianyungang Key Natural Source Antitumor Medicine Models and Performance
Table JIANGSU HENGRUI MEDICINE CO., LTD. CN 222 047 Lianyungang Natural Source Antitumor Medicine Business SWOT Analysis and Forecast
Table JIANGSU HENGRUI MEDICINE CO., LTD. CN 222 047 Lianyungang Natural Source Antitumor Medicine Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure JIANGSU HENGRUI MEDICINE CO., LTD. CN 222 047 Lianyungang Natural Source Antitumor Medicine Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure JIANGSU HENGRUI MEDICINE CO., LTD. CN 222 047 Lianyungang Natural Source Antitumor Medicine Sales Market Share (%) in Global (2012-2017)
Figure JIANGSU HENGRUI MEDICINE CO., LTD. CN 222 047 Lianyungang Natural Source Antitumor Medicine Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure JIANGSU HENGRUI MEDICINE CO., LTD. CN 222 047 Lianyungang Natural Source Antitumor Medicine Revenue Market Share (%) in Global (2012-2017)
Table MINAKEM HIGH POTENT BE 1435 Mont-Saint-Guibert Company Details and Competitors
Table MINAKEM HIGH POTENT BE 1435 Mont-Saint-Guibert Key Natural Source Antitumor Medicine Models and Performance
Table MINAKEM HIGH POTENT BE 1435 Mont-Saint-Guibert Natural Source Antitumor Medicine Business SWOT Analysis and Forecast
Table MINAKEM HIGH POTENT BE 1435 Mont-Saint-Guibert Natural Source Antitumor Medicine Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure MINAKEM HIGH POTENT BE 1435 Mont-Saint-Guibert Natural Source Antitumor Medicine Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure MINAKEM HIGH POTENT BE 1435 Mont-Saint-Guibert Natural Source Antitumor Medicine Sales Market Share (%) in Global (2012-2017)
Figure MINAKEM HIGH POTENT BE 1435 Mont-Saint-Guibert Natural Source Antitumor Medicine Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure MINAKEM HIGH POTENT BE 1435 Mont-Saint-Guibert Natural Source Antitumor Medicine Revenue Market Share (%) in Global (2012-2017)
Table NIPPON KAYAKU CO., LTD. JP 100-0005 Tokyo Company Details and Competitors
Table NIPPON KAYAKU CO., LTD. JP 100-0005 Tokyo Key Natural Source Antitumor Medicine Models and Performance
Table NIPPON KAYAKU CO., LTD. JP 100-0005 Tokyo Natural Source Antitumor Medicine Business SWOT Analysis and Forecast
Table NIPPON KAYAKU CO., LTD. JP 100-0005 Tokyo Natural Source Antitumor Medicine Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure NIPPON KAYAKU CO., LTD. JP 100-0005 Tokyo Natural Source Antitumor Medicine Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure NIPPON KAYAKU CO., LTD. JP 100-0005 Tokyo Natural Source Antitumor Medicine Sales Market Share (%) in Global (2012-2017)
Figure NIPPON KAYAKU CO., LTD. JP 100-0005 Tokyo Natural Source Antitumor Medicine Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure NIPPON KAYAKU CO., LTD. JP 100-0005 Tokyo Natural Source Antitumor Medicine Revenue Market Share (%) in Global (2012-2017)
Table PHYTON BIOTECH LLC CA V3M 6P7 Delta Company Details and Competitors
Table PHYTON BIOTECH LLC CA V3M 6P7 Delta Key Natural Source Antitumor Medicine Models and Performance
Table PHYTON BIOTECH LLC CA V3M 6P7 Delta Natural Source Antitumor Medicine Business SWOT Analysis and Forecast
Table PHYTON BIOTECH LLC CA V3M 6P7 Delta Natural Source Antitumor Medicine Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure PHYTON BIOTECH LLC CA V3M 6P7 Delta Natural Source Antitumor Medicine Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure PHYTON BIOTECH LLC CA V3M 6P7 Delta Natural Source Antitumor Medicine Sales Market Share (%) in Global (2012-2017)
Figure PHYTON BIOTECH LLC CA V3M 6P7 Delta Natural Source Antitumor Medicine Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure PHYTON BIOTECH LLC CA V3M 6P7 Delta Natural Source Antitumor Medicine Revenue Market Share (%) in Global (2012-2017)
Table POLYMED THERAPEUTICS, INC. US 77056 Houston Company Details and Competitors
Table Sanmar Speciality Chemicals Limited IN 600 086 Chennai Company Details and Competitors
Table SANOFI CHIMIE FR 94250 Gentilly Company Details and Competitors
Table SCINOPHARM TAIWAN, LTD. TW 74144 Shan-Hua Company Details and Competitors
Table TEVA CZECH INDUSTRIES S.R.O. CZ 747 70 Opava-Komarov Company Details and Competitors
Table Global Natural Source Antitumor Medicine Sales () by Regions (2012-2017)
Table Global Natural Source Antitumor Medicine Sales Share by Regions (2012-2017)
Figure Global Natural Source Antitumor Medicine Sales Market Share by Regions in 2016
Figure Global Natural Source Antitumor Medicine Sales Market Share by Regions in 2017
Table Global Natural Source Antitumor Medicine Revenue (Million USD) by Regions (2012-2017)
Table Global Natural Source Antitumor Medicine Revenue Market Share by Regions (2012-2017)
Figure Global Natural Source Antitumor Medicine Revenue Market Share by Regions in 2016
Figure Global Natural Source Antitumor Medicine Revenue Market Share by Regions in 2017
Table Global Natural Source Antitumor Medicine Price () by Regions (2012-2017)
Table North America Natural Source Antitumor Medicine Sales () by Regions (2012-2017)
Table North America Natural Source Antitumor Medicine Revenue (Million USD) by Regions (2012-2017)
Figure North America Natural Source Antitumor Medicine Sales () and Growth Rate (2012-2017)
Table Latin America Natural Source Antitumor Medicine Sales () by Regions (2012-2017)
Table Latin America Natural Source Antitumor Medicine Revenue (Million USD) by Regions (2012-2017)
Figure Latin America Natural Source Antitumor Medicine Sales () and Growth Rate (2012-2017)
Table Europe Natural Source Antitumor Medicine Sales () by Regions (2012-2017)
Table Europe Natural Source Antitumor Medicine Revenue (Million USD) by Regions (2012-2017)
Figure Europe Natural Source Antitumor Medicine Sales () and Growth Rate (2012-2017)
Table Asia & Pacific Natural Source Antitumor Medicine Sales () by Regions (2012-2017)
Table Asia & Pacific Natural Source Antitumor Medicine Revenue (Million USD) by Regions (2012-2017)
Figure Asia & Pacific Natural Source Antitumor Medicine Sales () and Growth Rate (2012-2017)
Table Africa & Middle East Natural Source Antitumor Medicine Sales () by Regions (2012-2017)
Table Africa & Middle East Natural Source Antitumor Medicine Revenue (Million USD) by Regions (2012-2017)
Figure Africa & Middle East Natural Source Antitumor Medicine Sales () and Growth Rate (2012-2017)
Table Global Natural Source Antitumor Medicine Sales Volume () by Key Players 2012-2017
Table Global Natural Source Antitumor Medicine Sales Volume Market Share by Key Players 2012-2017
Figure Global Natural Source Antitumor Medicine Sales Volume Market Share by Key Players 2016
Figure Global Natural Source Antitumor Medicine Sales Volume Market Share by Key Players 2017
Table Global Natural Source Antitumor Medicine Revenue (Million USD) by Key Players 2012-2017
Table Global Natural Source Antitumor Medicine Revenue Market Share by Key Players 2012-2017
Figure Global Natural Source Antitumor Medicine Revenue Market Share by Key Players 2016
Figure Global Natural Source Antitumor Medicine Revenue Market Share by Key Players 2017
Table Global Top Players Key Product Model and Market Performance
Table Global Top Players Key Target Consumers and Market Performance
Table Europe Natural Source Antitumor Medicine Sales Volume () by Key Players 2012-2017
Table Europe Natural Source Antitumor Medicine Sales Volume Market Share by Key Players 2012-2017
Figure Europe Natural Source Antitumor Medicine Sales Volume Market Share by Key Players 2016
Figure Europe Natural Source Antitumor Medicine Sales Volume Market Share by Key Players 2017
Table Europe Natural Source Antitumor Medicine Revenue (Million USD) by Key Players 2012-2017
Table Europe Natural Source Antitumor Medicine Revenue Market Share by Key Players 2012-2017
Figure Europe Natural Source Antitumor Medicine Revenue Market Share by Key Players 2016
Figure Europe Natural Source Antitumor Medicine Revenue Market Share by Key Players 2017
Table Europe Top Players Key Product Model and Market Performance
Table Europe Top Players Key Target Consumers and Market Performance
Table Global Natural Source Antitumor Medicine Sales () by Consumer (2012-2017)
Figure Global Natural Source Antitumor Medicine Sales Market Share by Consumer (2012-2017)
Figure Global Natural Source Antitumor Medicine Sales Market Share by Consumer in 2016
Figure Global Department of Oncology Natural Source Antitumor Medicine Sales () and Growth Rate (2012-2017)
Figure Global Department of Chemotherapy Natural Source Antitumor Medicine Sales () and Growth Rate (2012-2017)
Figure Global Pharmacology Natural Source Antitumor Medicine Sales () and Growth Rate (2012-2017)
Table Europe Natural Source Antitumor Medicine Sales () by Consumer (2012-2017)
Figure Europe Natural Source Antitumor Medicine Sales Market Share by Consumer (2012-2017)
Figure Europe Natural Source Antitumor Medicine Sales Market Share by Consumer in 2016
Figure Europe Department of Oncology Natural Source Antitumor Medicine Sales () and Growth Rate (2012-2017)
Figure Europe Department of Chemotherapy Natural Source Antitumor Medicine Sales () and Growth Rate (2012-2017)
Figure Europe Pharmacology Natural Source Antitumor Medicine Sales () and Growth Rate (2012-2017)
Figure Global Natural Source Antitumor Medicine Sales () and Growth Rate (%) Forecast (2017-2022)
Figure Global Natural Source Antitumor Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Natural Source Antitumor Medicine Price () Trend Forecast (2017-2022)
Table Global Natural Source Antitumor Medicine Sales () Forecast by Regions (2017-2022)
Table Global Natural Source Antitumor Medicine Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Natural Source Antitumor Medicine Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Natural Source Antitumor Medicine Sales Volume Share Forecast by Regions in 2022
Table Global Natural Source Antitumor Medicine Sales () Forecast by Application (2017-2022)
Figure Global Natural Source Antitumor Medicine Sales Volume Market Share Forecast by Application (2017-2022)
Figure Global Natural Source Antitumor Medicine Sales Volume Market Share Forecast by Application in 2022
Table Global Natural Source Antitumor Medicine Sales () Forecast by Natural Source (2017-2022)
Figure Global Natural Source Antitumor Medicine Sales () Forecast by Natural Source (2017-2022)
Figure Global Natural Source Antitumor Medicine Sales Volume Market Share Forecast by Natural Source in 2022
Table Global Natural Source Antitumor Medicine Sales () Forecast by (2017-2022)
Figure Global Natural Source Antitumor Medicine Sales () Forecast by (2017-2022)
Figure Global Natural Source Antitumor Medicine Sales Volume Market Share Forecast by in 2022
Figure Europe Natural Source Antitumor Medicine Sales () and Growth Rate (%) Forecast (2017-2022)
Figure Europe Natural Source Antitumor Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Europe Natural Source Antitumor Medicine Price () Trend Forecast (2017-2022)
Table Europe Natural Source Antitumor Medicine Sales () Forecast by Regions (2017-2022)
Table Europe Natural Source Antitumor Medicine Sales Volume Share Forecast by Regions (2017-2022)
Figure Europe Natural Source Antitumor Medicine Sales Volume Share Forecast by Regions (2017-2022)
Figure Europe Natural Source Antitumor Medicine Sales Volume Share Forecast by Regions in 2022
Table Europe Natural Source Antitumor Medicine Sales () Forecast by Application (2017-2022)
Figure Europe Natural Source Antitumor Medicine Sales Volume Market Share Forecast by Application (2017-2022)
Figure Europe Natural Source Antitumor Medicine Sales Volume Market Share Forecast by Application in 2022
Table Europe Natural Source Antitumor Medicine Sales () Forecast by Natural Source (2017-2022)
Figure Europe Natural Source Antitumor Medicine Sales () Forecast by Natural Source (2017-2022)
Figure Europe Natural Source Antitumor Medicine Sales Volume Market Share Forecast by Natural Source in 2022
Table Europe Natural Source Antitumor Medicine Sales () Forecast by (2017-2022)
Figure Europe Natural Source Antitumor Medicine Sales () Forecast by (2017-2022)
Figure Europe Natural Source Antitumor Medicine Sales Volume Market Share Forecast by in 2022